The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy

E-ISSN： 1873-5592|15|14|1341-1353

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.14, 2014-12, pp. : 1341-1353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

Current Drug Targets, Vol. 9, Iss. 5, 2008-05 ,pp. : 369-374

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of STAT3 for Cancer Therapy

Current Medicinal Chemistry, Vol. 18, Iss. 26, 2011-09 ,pp. : 4012-4018

Bentham Science Publishers

Access to resources Recommend Favorite

Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells

Current Cancer Drug Targets, Vol. 16, Iss. 7, 2016-08 ,pp. : 631-638

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 853-864

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 17, 2012-06 ,pp. : 2464-2471

Bentham Science Publishers

Access to resources Recommend Favorite